WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: EXORPHINASE

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on EXORPHINASE

Proof of use for EXORPHINASE

We do not have any records of a proof of use for EXORPHINASE at this moment.

Click here to add a proof of use for EXORPHINASE

Possible trademark infringements of EXORPHINASE

Basic Information about EXORPHINASE

Serial Number
87313098
Filing Date
25 Jan 2017
Registration Number
5368190
Registration Date
02 Jan 2018
Mark Drawing Code
4

Classifications

Declare the trademark use of EXORPHINASE on the blockchain with WikiTrademarks.io.

First use of EXORPHINASE anywhere
EXORPHINASE was first used on 17 Nov 1999 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns EXORPHINASE?

1. ProThera, Inc. Reno NV

2. ProThera, Inc. Reno CA

3. ProThera, Inc. Reno CA

Correspondent

Zachary A. Aria Blank Rome LLP
One Logan Square
8th Floor
Philadelphia, PA 19103

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on EXORPHINASE